YU42434B - Process for obtaining 2-guanidino-4-heteroarylthiazoles - Google Patents

Process for obtaining 2-guanidino-4-heteroarylthiazoles

Info

Publication number
YU42434B
YU42434B YU2464/81A YU246481A YU42434B YU 42434 B YU42434 B YU 42434B YU 2464/81 A YU2464/81 A YU 2464/81A YU 246481 A YU246481 A YU 246481A YU 42434 B YU42434 B YU 42434B
Authority
YU
Yugoslavia
Prior art keywords
heteroarylthiazoles
guanidino
obtaining
Prior art date
Application number
YU2464/81A
Other languages
English (en)
Other versions
YU246481A (en
Inventor
J L Lamattina
C A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU246481A publication Critical patent/YU246481A/xx
Publication of YU42434B publication Critical patent/YU42434B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU2464/81A 1980-10-14 1981-10-13 Process for obtaining 2-guanidino-4-heteroarylthiazoles YU42434B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19623180A 1980-10-14 1980-10-14
US06/293,574 US4374843A (en) 1980-10-14 1981-08-20 2-Guanidino-4-heteroarylthiazoles

Publications (2)

Publication Number Publication Date
YU246481A YU246481A (en) 1983-10-31
YU42434B true YU42434B (en) 1988-08-31

Family

ID=26891753

Family Applications (4)

Application Number Title Priority Date Filing Date
YU2464/81A YU42434B (en) 1980-10-14 1981-10-13 Process for obtaining 2-guanidino-4-heteroarylthiazoles
YU1053/83A YU42078B (en) 1980-10-14 1983-05-12 Process for obtaining 20guanidino-4-heteroarylthiazoles
YU1051/83A YU42076B (en) 1980-10-14 1983-05-12 Process for obtaining 2-guanidino-4-heteroarythiazoles
YU1052/83A YU42077B (en) 1980-10-14 1983-05-12 Process for obtaining 2-guanidino--heteroarylthiazoles

Family Applications After (3)

Application Number Title Priority Date Filing Date
YU1053/83A YU42078B (en) 1980-10-14 1983-05-12 Process for obtaining 20guanidino-4-heteroarylthiazoles
YU1051/83A YU42076B (en) 1980-10-14 1983-05-12 Process for obtaining 2-guanidino-4-heteroarythiazoles
YU1052/83A YU42077B (en) 1980-10-14 1983-05-12 Process for obtaining 2-guanidino--heteroarylthiazoles

Country Status (28)

Country Link
US (1) US4374843A (ru)
EP (1) EP0050458B1 (ru)
KR (1) KR850001858B1 (ru)
AR (3) AR228675A1 (ru)
AT (1) ATE11048T1 (ru)
AU (2) AU530589B2 (ru)
CA (1) CA1156239A (ru)
CS (1) CS231182B2 (ru)
DD (4) DD207913A5 (ru)
DE (1) DE3168067D1 (ru)
DK (1) DK453181A (ru)
ES (4) ES8301978A1 (ru)
FI (1) FI75821C (ru)
GR (1) GR75098B (ru)
HK (1) HK52387A (ru)
HU (2) HU186788B (ru)
IE (1) IE51642B1 (ru)
IL (1) IL64035A (ru)
KE (1) KE3707A (ru)
MY (1) MY8700512A (ru)
NO (1) NO159654C (ru)
NZ (1) NZ198629A (ru)
PH (3) PH17562A (ru)
PL (3) PL134491B1 (ru)
PT (1) PT73817B (ru)
SG (1) SG23487G (ru)
SU (1) SU1153829A3 (ru)
YU (4) YU42434B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
GB2122988B (en) * 1982-06-17 1986-06-11 Toyama Chemical Co Ltd Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative; intermediates
EP0156644A1 (en) * 1984-04-02 1985-10-02 Pfizer Inc. Process and intermediates for 4-acetylimidazoles
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
ES2031514T3 (es) * 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
EP0269239B1 (en) * 1986-10-29 1994-06-08 Pfizer Inc. Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and the crystalline dihydrochloride trihydrate thereof
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
WO1992016526A1 (en) * 1991-03-13 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
KR20080039979A (ko) * 2005-08-23 2008-05-07 우베 고산 가부시키가이샤 1-치환-5-아실이미다졸 화합물의 제법
EP2832731A4 (en) 2012-03-27 2015-08-19 Shionogi & Co AROMATIC HETEROCYCLIC CHAIN 5-CORE DERIVED DERIVATIVE HAVING TRPV4 INHIBITORY ACTIVITY
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516777A (fr) * 1966-08-02 1968-02-05 Innothera Lab Sa Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
US3519637A (en) * 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
HU168776B (ru) * 1973-11-09 1976-07-28
DE2614189A1 (de) * 1976-04-02 1977-10-20 Hoechst Ag Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
DE2961923D1 (en) * 1978-01-18 1982-03-11 Ici Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives

Also Published As

Publication number Publication date
CA1156239A (en) 1983-11-01
KE3707A (en) 1987-04-03
NO159654C (no) 1989-01-25
ES8306751A1 (es) 1983-06-01
FI75821C (fi) 1988-08-08
HK52387A (en) 1987-07-17
SG23487G (en) 1987-07-10
PH17562A (en) 1984-10-01
DK453181A (da) 1982-04-15
YU246481A (en) 1983-10-31
AU548992B2 (en) 1986-01-09
YU42078B (en) 1988-04-30
DD207718A5 (de) 1984-03-14
EP0050458B1 (en) 1985-01-02
ES8306749A1 (es) 1983-06-01
AR228674A1 (es) 1983-03-30
HU191895B (en) 1987-04-28
FI813177L (fi) 1982-04-15
ES506216A0 (es) 1982-12-16
DE3168067D1 (en) 1985-02-14
ES8306750A1 (es) 1983-06-01
DD207913A5 (de) 1984-03-21
DD202293A5 (de) 1983-09-07
CS750081A2 (en) 1984-02-13
ES515158A0 (es) 1983-06-01
ES515159A0 (es) 1983-06-01
US4374843A (en) 1983-02-22
ES8301978A1 (es) 1982-12-16
IE51642B1 (en) 1987-01-21
IL64035A0 (en) 1982-01-31
SU1153829A3 (ru) 1985-04-30
PT73817B (en) 1983-11-07
IL64035A (en) 1986-01-31
YU42076B (en) 1988-04-30
YU42077B (en) 1988-04-30
ES515157A0 (es) 1983-06-01
AR229703A1 (es) 1983-10-31
YU105283A (en) 1983-10-31
CS231182B2 (en) 1984-10-15
PL133712B1 (en) 1985-06-29
NO813442L (no) 1982-04-15
PL135331B1 (en) 1985-10-31
GR75098B (ru) 1984-07-13
HU186788B (en) 1985-09-30
EP0050458A2 (en) 1982-04-28
ATE11048T1 (de) 1985-01-15
NZ198629A (en) 1985-02-28
AU3206284A (en) 1984-11-29
PL134491B1 (en) 1985-08-31
DD207719A5 (de) 1984-03-14
PL241643A1 (en) 1983-11-21
PL233430A1 (en) 1983-11-21
KR830007638A (ko) 1983-11-04
EP0050458A3 (en) 1982-09-01
FI75821B (fi) 1988-04-29
AR228675A1 (es) 1983-03-30
NO159654B (no) 1988-10-17
YU105383A (en) 1983-10-31
AU530589B2 (en) 1983-07-21
MY8700512A (en) 1987-12-31
IE812384L (en) 1982-04-14
KR850001858B1 (ko) 1985-12-28
PL241644A1 (en) 1983-11-21
PH17856A (en) 1985-01-09
YU105183A (en) 1983-10-31
PT73817A (en) 1981-11-01
AU7628781A (en) 1982-04-22
PH18467A (en) 1985-07-18

Similar Documents

Publication Publication Date Title
YU144288A (en) Process for obtaining new substituted pyrimidins
YU42076B (en) Process for obtaining 2-guanidino-4-heteroarythiazoles
YU221581A (en) Process for obtaining isoxazolyl-benzamides
GB2082172B (en) Process for preparing n-alkyl-alkylenediamines
RO82720B (ro) Procedeu de stabilizare a unui agent antibacterian liofilizat de beta-lactama
YU164481A (en) Process for obtaining isoxazolyl-imidazolidinone
YU42734B (en) Process for obtaining new imidazolyl-pyridine
YU228886A (en) Process for obtaining new alphasulphonyloxiketone-acethale
YU114286A (en) Process for making 2-mercaptoethylaminhydrohalide
YU277781A (en) Process for obtaining new acylcarbamides
PT72348A (en) Process for preparing kijanimicin
YU243681A (en) Process for obtaining buspyrone
YU193781A (en) Process for obtaining 11-hydroxy-13-oxa-prostaglandins
DE3161061D1 (en) Process for preparing arylacetaldehydes
YU42584B (en) Process for obtaining 4-carbamoyloxy-oxazaphosphorine
YU70881A (en) New process for obtaining new 2-haloacetamides
DE3161108D1 (en) Process for preparing cyclopentenolones
YU71081A (en) Process for obtaining 2-haloacetamides
YU184881A (en) Process for obtaining 4-amino-12-dihydrocarbyl-pyrazolidine
DE3165126D1 (en) Process for preparing cyclopentenolones
GB2082160B (en) Process for obtaining senarmontite
YU42338B (en) Process for obtaining estradiol-17-polyphosphate
YU43219B (en) Process for obtaining l-lyzine
YU68280A (en) Process for obtaining n-alkyl-n-nitroso-urea
DE3168346D1 (en) Process for preparing n-cyanolactames